combination of dehydroepiandrosteron and aromatasehemmern and use of this combination in the manufacture of a medicinal product for the treatment of relative and absolute androgenmangels in man

摘要

The present invention concerns the combination of dehydroepiandrosterone (DHEA) and at least one aromatase inhibitor and the use of such a combination to produce a medicament for treating relative and/or absolute androgen deficiency in men. Selective aromatase inhibitors such as atamestan, formestan, pentrozol, aramidex, fadrozol, CGS 20267 and/or vorozol, are preferred for producing the medicament according to the invention.